Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bipolar Disorder Integrative Staging: Incorporating Biomarkers Into Progression Across Stages

NCT07343739 is registered in ClinicalTrials.gov with ASST Fatebenefratelli Sacco as lead sponsor.

NCT NCT07343739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07343739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bipolar Disorder Integrative Staging: Incorporating Biomarkers Into Progression Across Stages
Lead sponsor
ASST Fatebenefratelli Sacco
Phase
Observational
Overall status
Active, not recruiting
Start date
November 8, 2023
Completion date
May 20, 2026
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder